Ubl Philipp, Gincu Tatiana, Keilani Mohammad, Ponhold Lothar, Crevenna Richard, Niederle Bruno, Hacker Marcus, Li Shuren
Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Endocrine. 2014 Aug;46(3):549-53. doi: 10.1007/s12020-013-0109-6. Epub 2013 Nov 23.
The aim of this study was to compare the side effects of the pentagastrin test and the calcium stimulation test in patients with increased basal calcitonin concentration, especially the gender-specific differences of side effects. A total of 256 patients (123 females and 133 males, mean age of 56 ± 27 years, range 21-83 years) had both pentagastrin and calcium stimulation tests. All patients filled in a questionnaire regarding the side effects within 30 min after completion of the stimulation tests. The differences of side effects between female and male patients as well as between the pentagastrin stimulation test and the calcium stimulation test were evaluated. Warmth feeling was the most frequent occurring side effect in all patients who had both pentagastrin and calcium stimulation tests, followed by nausea, altered gustatory sensation, and dizziness. The incidences of urgency to micturate (p < 0.05) and dizziness (p < 0.05) were significantly increased in the female patients as compared to male patients by calcium stimulation test. Significant higher incidences of urgency to micturate (p < 0.05) and warmth feeling (p < 0.05) were found by calcium stimulation test as compared with those by pentagastrin test in female patients. The incidences of nausea (p < 0.05) and abdominal cramping (p < 0.05) in male patients were significantly higher by pentagastrin stimulation test than by calcium stimulation test. There is a significant gender-specific difference in side effects induced by calcium stimulation test. Female patients have fewer side effects by pentagastrin test than by calcium stimulation test. Male patients may tolerate the calcium stimulation test better than the pentagastrin test.
本研究的目的是比较基础降钙素浓度升高患者中五肽胃泌素试验和钙刺激试验的副作用,尤其是副作用的性别差异。共有256例患者(123例女性和133例男性,平均年龄56±27岁,范围21 - 83岁)接受了五肽胃泌素和钙刺激试验。所有患者在刺激试验完成后30分钟内填写了一份关于副作用的问卷。评估了女性和男性患者之间以及五肽胃泌素刺激试验和钙刺激试验之间副作用的差异。在所有接受五肽胃泌素和钙刺激试验的患者中,温热感是最常见的副作用,其次是恶心、味觉改变和头晕。与男性患者相比,女性患者在钙刺激试验后尿急(p<0.05)和头晕(p<0.05)的发生率显著增加。与五肽胃泌素试验相比,女性患者在钙刺激试验后尿急(p<0.05)和温热感(p<0.05)的发生率显著更高。男性患者在五肽胃泌素刺激试验后恶心(p<0.05)和腹部绞痛(p<0.05)的发生率显著高于钙刺激试验。钙刺激试验引起的副作用存在显著的性别差异。女性患者接受五肽胃泌素试验的副作用比钙刺激试验少。男性患者对钙刺激试验的耐受性可能比五肽胃泌素试验更好。